Comparison of the Efficacy of Two Microsphere Embolic Agents for Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma Patients

Shao-Hua Lee Chia-Ying Lin Ya-Chun Hsu Yi-Sheng Liu Ming-Tsung Chuang Ming-Ching Ou 2020년

논문상세정보

인용/피인용

Transcatheter embolization therapy in liver cancer : an update of clinical evidences
Wang YX [2015]
Transarterial therapy for hepatocellular carcinoma : which technique is more effective? A systematic review of cohort and randomized studies
Marelli L [2007]
Transarterial chemoembolization : Evidences from the literature and applications in hepatocellular carcinoma patients
Facciorusso A [2015]
The arterial distribution of Embozene and Embosphere microspheres in sheep kidney and uterus embolization models
Verret V [2011]
Pulmonary complications of novel antineoplastic agents for solid tumors
Vahid B [2008]
Hepatocellular carcinoma : a review
Balogh J [2016]
Design and endpoints of clinical trials in hepatocellular carcinoma
Llovet JM [2008]
Comparative in vitro evaluation of microspherical embolisation agents
Lewis AL [2006]
Chemoembolization of hepatocellular carcinoma
Lencioni R [2013]
Bland embolization in patients with unresectable hepatocellular carcinoma using precise, tightly sizecalibrated, anti-inflammatory microparticles : first clinical experience and one-year follow-up
Bonomo G [2010]
An overview of embolic agents
Vaidya S [2008]
American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma
Bruix J [2005]